Senior insider sale
Chief Development Officer at RAPPORT THERAPEUTICS, INC. — senior position signals high conviction
$573.6K
11.88K shares
What this filing means
YELESWARAM KRISHNASWAMY plans to sell 11.88K shares of RAPPORT THERAPEUTICS, INC. valued at approximately $573.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/24/2026ACC: 0001950047-26-008594
Officer· Chief Development Officer
Since Feb 2026
11.88K
Shares to sell
$573.6K
Approx. market value
11.47K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Founders Shares
N/A
6/9/2024
11.47KTotal acquired11.47K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/9/2024 | Founders Shares N/A | 11.47K | — |
| Total | 11.47K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
404.00
Market value
$20.2K
8/19/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
11.47K
Market value
$553.4K
8/24/2026
Total
Units
11.88K
Value
$573.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/19/2026 | 404.00 | $20.2K | — | Completed |
| Planned — Approximate Date | ||||
8/24/2026 | 11.47K | $553.4K | NASDAQ | Planned |
| Total | 11.88K | $573.6K | ||